Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.
about
Conjugate vaccines for preventing meningococcal C meningitis and septicaemiaConjugate vaccines for preventing meningococcal C meningitis and septicaemiaFactors contributing to the immunogenicity of meningococcal conjugate vaccinesCharacteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis vaGlobal practices of meningococcal vaccine use and impact on invasive disease.Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine.Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive diseaseMaintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in EnglandConjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidatesImmunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.MenAfriVac as an Antitetanus VaccineSeroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyRecombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier proteinInteractions of conjugate vaccines and co-administered vaccinesImmune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.Immunogenicity of MenACWY-CRM in Korean Military Recruits: Influence of Tetanus-Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY-CRM.Prevention of meningococcal serogroup C disease by NeisVac-C.Advances with vaccination against Neisseria meningitidis.Evolving meningococcal immunization strategies.Update on the use of meningococcal serogroup C CRM₁₉₇-conjugate vaccine (Meningitec) against meningitis.Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study.
P2860
Q24235722-1731DB06-752F-405B-94B2-8176F604539CQ24244951-7E97615E-B612-4AF3-894C-ED33944F1CF8Q28828544-CCFBA98F-3F6D-49D0-B8B6-598333F23D96Q30248749-594393D7-8570-4A1B-A26C-A4318C29C175Q33397450-2ED0123C-D69C-4D93-8A14-65F0F9EC31C8Q33768673-0F8F466C-AA50-4A4B-9B0F-55524F374E1DQ33850840-63286AF0-C392-4EAB-877B-6698DD712165Q33959308-0106B052-1AF1-4913-927D-90015A37532EQ34034071-DB6F158A-216B-4454-ADEF-6FB7B452C702Q34155231-6DEC0AEE-6847-4957-B7CE-3E0EC987F627Q34170021-4691F407-C79B-40B9-84CE-D66E00C31BE2Q34606343-187318A5-E27E-44C6-B125-D71E73118F1DQ34975007-DD7E0987-EDD8-4E23-B0D9-59124B9A1F15Q35187182-4F1D527C-2BFF-4026-BE7D-1A777CF4E36AQ35598188-1A57C9FD-CC7F-41F3-9EA4-544F25F1DBB2Q35783483-554E2B59-EA0D-41CA-BC02-8D88972AB1F2Q35783606-3536356E-46C2-4526-9DD6-C354DDD2961EQ35923728-270A4B93-4A94-43ED-923F-77A05BEC969BQ35925379-A425E9DE-D2DC-4464-83BF-E2B25B46BF2AQ36045855-7491DC74-9B12-4828-87FB-A3D4C95C019FQ36265023-DCB24A00-2580-43FC-9663-9DB4EB0A9867Q36738155-4C55189A-D321-42A0-B430-E58E91DB1898Q36746962-5DF98A7F-2F19-4979-9B65-986DF7C3F267Q37130164-B2344605-B8CD-4171-90B2-5D1978BD54C0Q37163685-6F3931E6-F803-4075-ACF9-A3D5E3BFDE29Q37231925-9408851C-640F-4B5D-B479-49645C2BB70BQ37403478-A0DDC7E8-6723-4539-B2C0-A262AC7468A9Q38040527-08A560FB-6C40-4368-81A8-87DCE0331031Q38286082-EF034142-B827-4A3A-9B27-61B6CEFF1D3FQ38631381-78CFB164-3023-4FEF-BDEB-AF584F290A69Q42270579-E7703DB3-02DF-4D1D-A3A0-B27989BE203A
P2860
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of vaccination with car ...... s as predictors of protection.
@ast
Effect of vaccination with car ...... s as predictors of protection.
@en
Effect of vaccination with car ...... s as predictors of protection.
@nl
type
label
Effect of vaccination with car ...... s as predictors of protection.
@ast
Effect of vaccination with car ...... s as predictors of protection.
@en
Effect of vaccination with car ...... s as predictors of protection.
@nl
prefLabel
Effect of vaccination with car ...... s as predictors of protection.
@ast
Effect of vaccination with car ...... s as predictors of protection.
@en
Effect of vaccination with car ...... s as predictors of protection.
@nl
P2093
P2860
P50
P1476
Effect of vaccination with car ...... s as predictors of protection.
@en
P2093
Andrew Robinson
Carol Thornton
Dorothea Sesardic
Elizabeth Miller
Jamie Findlow
Joanna Southern
Keith Cartwight
Michael Corbel
Moya Burrage
Nick Andrews
P2860
P304
P356
10.1128/IAI.70.9.4946-4954.2002
P407
P577
2002-09-01T00:00:00Z